Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia.

W Katon, R Ries

    The Journal of Family Practice
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    The Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition (DSM-III) narrowed schizophrenia diagnosis, increasing affective disorder diagnoses. Research suggests neurological damage in some schizophrenia patients, with dopamine excess implicated as a cause.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of AC loss down to 25 K in a REBCO racetrack coil for electrical aircraft motor.

    Scientific reports·2022
    Same author

    Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
    Same author

    The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in India.

    Contemporary clinical trials·2017
    Same author

    Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders.

    Psychological medicine·2012
    Same author

    Stability analysis for grating-tuned strong-external-feedback semiconductor lasers.

    Applied optics·2010
    Same author

    Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo.

    Neuroscience·2004
    Same journal

    Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

    The Journal of family practice·2023
    Same journal

    Preventing RSV in children and adults: A vaccine update.

    The Journal of family practice·2023
    Same journal

    Essential oils: How safe? How effective?

    The Journal of family practice·2023
    Same journal

    51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

    The Journal of family practice·2023
    Same journal

    Renewing the dream.

    The Journal of family practice·2023
    Same journal

    55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

    The Journal of family practice·2023
    See all related articles

    Area of Science:

    • Psychiatry
    • Neurology
    • Mental Health

    Background:

    • The Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition (DSM-III) introduced revised diagnostic criteria for schizophrenia.
    • These changes have significantly impacted diagnostic trends in the United States.

    Purpose of the Study:

    • To analyze the impact of the DSM-III's revised diagnostic criteria for schizophrenia.
    • To explore the evolving understanding of schizophrenia's etiology and treatment.

    Main Methods:

    • Review of diagnostic criteria changes in the DSM-III.
    • Analysis of diagnostic shifts in schizophrenia and affective disorders.
    • Examination of current research on schizophrenia etiology and treatment.

    Main Results:

    Related Experiment Videos

    • The "narrower" DSM-III definition led to a decrease in schizophrenia diagnoses and an increase in affective disorder diagnoses.
    • A subgroup of schizophrenia patients exhibits neurological damage and dementia-like clinical courses.
    • Dopamine excess in the mesolimbic system is a primary inferred cause for most schizophrenia cases.
    • Antipsychotic medications, targeting dopamine receptor blockade, are effective for positive symptoms but less so for negative symptoms.

    Conclusions:

    • The DSM-III criteria have altered schizophrenia diagnosis rates.
    • Schizophrenia may involve neurological underpinnings in certain patient groups.
    • Dopamine pathways are central to schizophrenia pathophysiology and treatment targets.
    • Current antipsychotic treatments show limitations in addressing negative symptoms of schizophrenia.